The troubled Advisory Board Co. is weighing a merger with Evolent Health, a technology firm in which it currently invests.
Activist investor Elliott Management has agreed not to launch a takeover or fight for board seats at the Advisory Board Co. while the healthcare consultancy and technology company explores strategic alternatives, including a possible sale.
Advisory Board Co., which recently trimmed 5.7% of its workforce, announced it is considering a potential sale. In recent months, the consultancy said it was restructuring as a result of some expected losses.
The Advisory Board Co. will lay off about 220 employees, or 5.7% of its total workforce, as part of a restructuring plan. The healthcare consulting firm says revenue dropped after the election “as members reassessed their strategy and path forward.”
MACRA will fuel demand for the services of a burgeoning crop of vendors that specialize in helping providers collect, analyze and report performance data.
The migration of lucrative joint-replacement surgeries to outpatient settings will cause friction between surgeons and hospitals, and it raises questions about the premise of Medicare's new bundled-payment initiative for hospital-based procedures.
Evolent's technology and consulting platform can help identify high-risk patients by analyzing data from multiple sources and then create physician-driven care-management plans.
The latest iteration of Medicare's accountable care experiment paves the way for more doctors and hospitals to evolve toward starting their own Medicare Advantage plans, stoking a trend that's already well underway.
Competition is building in the cancer-care field, as hospitals, health systems and physician groups are constructing new cancer centers in response to the aging of the baby boomers and a projected increase in cancer diagnoses over the next 20 years.
The VHA-UHC Alliance's planned acquisition of MedAssets' group purchasing organization and consulting business could open the market to disruptive models, experts and industry insiders say.
Hospitals and health systems have been spending more on advertising in recent years, with an emphasis on educating patients and engaging them in their growing role as healthcare consumers.
The hips and knees of the nation's seniors were an obvious target for Medicare's first mandatory test of an alternative payment model for hospitals. But joint replacement isn't the only possible target. Hospitals are now on notice that Medicare will move ahead if they don't do it on their own.